Apolipoprotein E regulatory region genotype in schizophrenia

Neuroscience Letters

Volumn 256, Issue 1, 1998, Pages 57-60

  Shinkai, Takahiro ^a   Ohmori, Osamu ^a   Kojima, Hideki ^a   Terao, Takeshi ^a   Suzuki, Takashi ^a   Abe, Kazuhiko ^a   Nakamura, Jun ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Alzheimer's disease; Apolipoprotein E; Chromosome 19; Genetic polymorphism; Regulatory region; Schizophrenia

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENES, REGULATOR; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 0032582781     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00761-7     Document Type: Article

References (20)

1. Arnold S.E., Franz B.R., Trojanowski J.Q. Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol. Aging. 15:1994;299-303.
2. Artiga M.J., Bullido M.J., Sastre I., Recuero M., Garcia M.A., Aldudo J., Vázquez J., Valdivieso F. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett. 421:1998;105-108.
3. Brousseau T., Legrain S., Berr C., Gourlet V., Vidal O., Amouyel P. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology. 44:1994;342-344.
4. Das H.K., McPherson J., Bruns G.A.P., Karathanasis S.K., Breslow J.L. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 260:1985;6240-6247.
5. Forsell Y., Basun H., Corder E.H., Lannfelt L., Winblad B. Psychotic symptoms and apolipoprotein E genotypes in an elderly population. Biol. Psychiatry. 44:1998;139-140.
6. Harrington C.R., Roth M., Xuereb J.H., McKenna P.J., Wischik C.M. Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci. Lett. 202:1995;101-104.
7. Jönsson E., Lannfelt L., Engvall B., Sedvall G. Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. Eur. Arch. Psychiatry Clin. Neurosci. 246:1996;182-184.
8. Krawiecka M., Goldbrg D., Vaughan M. A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta. Psychiatr. Scand. 55:1977;299-308.
9. Lyketsos C.G., Baker L., Warren A., Steele C., Brandt J., Steinberg M., Kopunek S., Baker A. Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype. J. Neuropsych. Clin. Neurosci. 9:1997;64-67.
10. Niizato K., Arai T., Kuroki N., Kase K., Iritani S., Ikeda K. Autopsy study of Alzheimer's disease brain pathology in schizophrenia. Schizophr. Res. 31:1998;177-184.
11. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
12. Ohara K., Nagai M., Ohara K. Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet. 350:1997;1857.
13. Overall J.E., Gorham D.E. The brief psychiatric rating scale. Psychol. Rep. 10:1961;799-812.
14. Pickar D., Malhotra A.K., Rooney W., Breier A., Goldman D. Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet. 350:1997;930-931.
15. Pitas R.E., Boyles J.K., Lee S.H., Foss D., Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta. 917:1987;148-161.
16. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
17. Purohit D.P., Davidson M., Perl D.P., Powchik P., Haroutunian V.H., Bierer L.M., McCrystal J., Losonczy M., Davis K.L. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol. Psychiatry. 33:1993;255-260.
18. Rietschel M., Krauß H., Müller D.J., Nothen M.M., Macciardi F. Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet. 350:1997;1857-1858.
19. Sorbi S., Nacmias B., Tedde A., Latorraca S., Forleo P., Guarnieri B.M., Petruzzi C., Daneluzzo E., Ortenzi L., Piacentini S., Amaducci L. No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. Neurosci. Lett. 244:1998;118-120.
20. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency to type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.